Cite
Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes
MLA
Aso, Yoshimasa, et al. “Low-Dose Pioglitazone Increases Serum High Molecular Weight Adiponectin and Improves Glycemic Control in Japanese Patients with Poorly Controlled Type 2 Diabetes.” Diabetes Research & Clinical Practice, vol. 85, no. 2, Aug. 2009, pp. 147–52. EBSCOhost, https://doi.org/10.1016/j.diabres.2009.05.015.
APA
Aso, Y., Hara, K., Ozeki, N., Yatsuka, C., Nakano, T., Matsumoto, S., Suetsugu, M., Nakamachi, T., Takebayashi, K., Haruki, K., & Inukai, T. (2009). Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes. Diabetes Research & Clinical Practice, 85(2), 147–152. https://doi.org/10.1016/j.diabres.2009.05.015
Chicago
Aso, Yoshimasa, Kenji Hara, Noriyuki Ozeki, Chikako Yatsuka, Tomoki Nakano, Sachiko Matsumoto, Mariko Suetsugu, et al. 2009. “Low-Dose Pioglitazone Increases Serum High Molecular Weight Adiponectin and Improves Glycemic Control in Japanese Patients with Poorly Controlled Type 2 Diabetes.” Diabetes Research & Clinical Practice 85 (2): 147–52. doi:10.1016/j.diabres.2009.05.015.